WebZacks. Atara Biotherapeutics, Inc. develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant ... WebApr 12, 2024 · 7 brokers have issued twelve-month price targets for Atara Biotherapeutics' stock. Their ATRA share price forecasts range from $3.00 to $50.00. On average, they expect the company's share price to reach $19.25 in the next year. This suggests a possible upside of 594.9% from the stock's current price. View analysts price targets for ATRA or …
ATRA Stock News ATARA BIOTHERAPEUTICS Stock Price …
WebGet the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebApr 3, 2024 · Atara Biotherap Market Capitalization is currently at 854.22 M. Market Capitalization is the total market value of Atara Biotherap's equity. It is one of many … quikrete powerloc jointing sand near me
ATRA - Atara Biotherapeutics Inc Stock quote - CNNMoney.com
WebApr 15, 2024 · With the market capitalization of Atara Biotherapeutics Inc. currently standing at about $258.99 million, investors are eagerly awaiting this quarter’s results, … WebMar 31, 2024 · Market Cap Chart Since October 16, 2014, Atara Biotherapeutics, Inc.'s market cap has increased from $53.10M to $282.02M, an increase of 431.16%. That is a … WebInteractive chart of historical net worth (market cap) for Atara Biotherapeutics (ATRA) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Atara Biotherapeutics net worth as of March 31, 2024 is $0.27B . quikrete sand/topping mix instructions